TherapeuticsMD is a pharmaceutical royalty company, primarily collecting royalties from its licensees. Co. out-licenses its products and collects royalties, after granting a license to commercialize its IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD® and vitaMedMD® brands in the US and its possessions and territories and assigning its license to commercialize ANNOVERA in the US and its possessions and territories to Mayne Pharma LLC. Co. also has license agreements with partners to commercialize IMVEXXY and BIJUVA outside of the US. The TXMD stock yearly return is shown above.
The yearly return on the TXMD stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the TXMD annual return calculation with any dividends reinvested as applicable (on ex-dates).
|